NO2994485T3 - - Google Patents

Info

Publication number
NO2994485T3
NO2994485T3 NO14722194A NO14722194A NO2994485T3 NO 2994485 T3 NO2994485 T3 NO 2994485T3 NO 14722194 A NO14722194 A NO 14722194A NO 14722194 A NO14722194 A NO 14722194A NO 2994485 T3 NO2994485 T3 NO 2994485T3
Authority
NO
Norway
Application number
NO14722194A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2994485T3 publication Critical patent/NO2994485T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Water Supply & Treatment (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
NO14722194A 2013-05-06 2014-05-06 NO2994485T3 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13305593 2013-05-06
EP14722194.9A EP2994485B1 (fr) 2013-05-06 2014-05-06 Procede continu en plusieurs etapes destine a la purification des anticorps
PCT/EP2014/059246 WO2014180852A1 (fr) 2013-05-06 2014-05-06 Procédé continu à étapes multiples pour la purification d'anticorps

Publications (1)

Publication Number Publication Date
NO2994485T3 true NO2994485T3 (fr) 2018-06-09

Family

ID=48430636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14722194A NO2994485T3 (fr) 2013-05-06 2014-05-06

Country Status (19)

Country Link
US (1) US10793622B2 (fr)
EP (2) EP3301115B1 (fr)
JP (2) JP6463734B2 (fr)
KR (1) KR102272851B1 (fr)
CN (2) CN105358572A (fr)
AU (1) AU2014264697B2 (fr)
BR (1) BR112015027812B1 (fr)
CA (1) CA2911462C (fr)
CY (1) CY1125281T1 (fr)
DK (2) DK2994485T3 (fr)
ES (2) ES2905675T3 (fr)
HU (2) HUE057119T2 (fr)
IL (1) IL242408B (fr)
MX (1) MX368177B (fr)
NO (1) NO2994485T3 (fr)
RU (1) RU2662668C2 (fr)
SG (1) SG11201508968XA (fr)
TW (2) TWI631132B (fr)
WO (1) WO2014180852A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
CN104884147A (zh) * 2012-10-24 2015-09-02 建新公司 使用mes和mops作为流动相改性剂从多峰树脂洗脱生物分子
JPWO2015041218A1 (ja) * 2013-09-17 2017-03-02 株式会社カネカ 新規抗体精製方法及びそれから得られる抗体（ＮｏｖｅｌＡｎｔｉｂｏｄｙＰｕｒｉｆｉｃａｔｉｏｎＭｅｔｈｏｄａｎｄＡｎｔｉｂｏｄｙｏｂｔａｉｎｅｄｔｈｅｒｅｆｒｏｍ）、並びに陽イオン交換基を用いた新規抗体精製法及びそれから得られる抗体（ＮｏｖｅｌＡｎｔｉｂｏｄｙＰｕｒｉｆｉｃａｔｉｏｎｍｅｔｈｏｄｕｓｉｎｇＣａｔｉｏｎＥｘｃｈａｎｇｅｒａｎｄＡｎｔｉｂｏｄｙｏｂｔａｉｎｅｄｔｈｅｒｅｆｒｏｍ）
CA2935960C (fr) 2014-01-08 2023-01-10 Bart Lipkens Dispositif d'acoustophorese avec double chambre acoustophoretique
GB201503578D0 (en) * 2015-03-03 2015-04-15 Ge Healthcare Bio Sciences Ab Sanitization method for affinity chromatography matrices
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
EP3015542A1 (fr) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Installation modulaire et procédé de production continue, présentant une réduction de germe et/ou préparation d'un produit
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US20170101437A1 (en) * 2015-10-09 2017-04-13 Hetero Drugs Ltd. Process for purification of darbepoetin alfa
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
EP3512884A4 (fr) * 2016-09-14 2020-09-16 Kinbio Ltd. Procédés de purification et de qualification d'anticorps
CN110494543A (zh) 2016-10-19 2019-11-22 弗洛设计声能学公司 通过声学的亲和细胞提取
MX2019011343A (es) * 2017-03-24 2019-11-18 Council Scient Ind Res Un procedimiento para la purificacion de fragmentos de anticuerpos recombinantes.
GB201711481D0 (en) * 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
US11584777B2 (en) 2017-08-31 2023-02-21 Green Cross Corporation Method for purifying a sulfatase protein
SG11202003907WA (en) 2017-12-14 2020-05-28 Flodesign Sonics Inc Acoustic transducer drive and controller
WO2019183334A1 (fr) 2018-03-21 2019-09-26 Waters Technologies Corporation Préparation d'échantillon à base d'affinité élevée sans anticorps, sorbants, dispositifs et méthodes
EP3546475A1 (fr) 2018-03-27 2019-10-02 Sanofi Processus d'écoulement intégral pour purifier des protéines recombinées
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
KR102337683B1 (ko) * 2018-09-21 2021-12-13 주식회사 녹십자 고효율 항-tfpi 항체 조성물
EP3636657A1 (fr) * 2018-10-08 2020-04-15 Ablynx N.V. Procédé de purification d'anticorps sans chromatographie
WO2020084503A1 (fr) * 2018-10-26 2020-04-30 Cadila Healthcare Limited Composition comprenant un anticorps ayant un niveau réduit de variants basiques de celui-ci
WO2020183332A1 (fr) * 2019-03-11 2020-09-17 Intas Pharmaceuticals Ltd. Purification d'adalimumab à l'aide d'une chromatographie en tandem
BR112021019217A2 (pt) * 2019-04-03 2021-11-30 Genzyme Corp Produção contínua de proteínas recombinantes
CN114026108B (zh) * 2019-06-28 2024-09-10 夏尔巴生物技术(苏州)有限公司 无缝连续流层析方法
JP2023500775A (ja) * 2019-09-23 2023-01-11 メルク・シャープ・アンド・ドーム・エルエルシー 宿主細胞タンパク質が減少し、ポリソルベート－８０安定性が増加した、抗ｃｔｌａ４モノクローナル抗体を含む方法および組成物
KR102154952B1 (ko) * 2020-02-21 2020-09-10 프레스티지바이오로직스 주식회사 아달리무맙의 Non-Protein A 정제방법
CN112574321B (zh) * 2020-12-30 2023-10-20 上海赛金生物医药有限公司 一种捕获单克隆抗体-肿瘤坏死因子融合蛋白的亲和纯化方法
WO2022234412A1 (fr) 2021-05-03 2022-11-10 Lupin Limited Procédé de purification de protéines de fusion fc

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626008B2 (en) 1987-10-23 1992-07-23 Schering Corporation Method of purifying protein
DK0668877T3 (da) * 1993-09-21 1999-09-13 Hemosol Inc Fortrængningschromatografisk fremgangsmåde og oprenset hæmoglobinprodukt
CA2106612C (fr) 1993-09-21 2001-02-06 Diana Pliura Processus de chromatographie a deplacement
US5891741A (en) 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
CN1136317C (zh) 1999-03-12 2004-01-28 中国人民解放军第四军医大学 单克隆抗体双段和单段的制备方法
US20020009445A1 (en) 2000-07-12 2002-01-24 Yansheng Du Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
US6602855B2 (en) 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
CN1504482A (zh) * 2002-12-03 2004-06-16 北京优力凯生物技术有限责任公司 无细胞百日咳抗原蛋白的分离纯化方法
WO2005103084A2 (fr) 2004-04-21 2005-11-03 The Brigham And Women's Hospital, Inc. Peptides de liaison a poly-n-acetyl glucosamine (pnag/dpnag) et leurs procedes d'utilisation
BRPI0518216C8 (pt) * 2004-10-21 2017-03-21 Ge Healthcare Bio Sciences Ab ligante de cromatografia, métodos de preparação de uma matriz de separação, e de separação de um ou mais anticorpos de um ou mais outros compostos em uma amostra líquida, matriz de separação, e, coluna de cromatografia descartável.
EP3312196B1 (fr) 2005-03-23 2019-07-17 Genmab A/S Anticorps dirigés contre cd38 pour le traitement du myélome multiple
CN1814775A (zh) 2005-12-06 2006-08-09 中国海洋大学 一种抗病毒活性寡聚肽的制备方法
EP1914242A1 (fr) * 2006-10-19 2008-04-23 Sanofi-Aventis Nouveau anticorps Anti-CD38 pour le traitement du cancer
WO2009007451A1 (fr) * 2007-07-11 2009-01-15 Novo Nordisk A/S Purification du facteur viii à l'aide d'une résine en mode mixte ou multimodal
EP2207568B1 (fr) 2007-11-16 2017-05-31 The Rockefeller University Anticorps spécifiques de la forme de protofibrille de protéine bêta-amyloïde
TWI472339B (zh) * 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
JP2011514895A (ja) * 2008-02-29 2011-05-12 バイオジェン・アイデック・エムエイ・インコーポレイテッド 精製免疫グロブリン融合タンパク質およびその精製方法
EP2281000A2 (fr) 2008-05-15 2011-02-09 Novo Nordisk A/S Procédé de purification d'anticorps
AU2009270723A1 (en) * 2008-07-18 2010-01-21 Grifols Therapeutics Inc. Method of preparing alpha-1 proteinase inhibitor
EP2360183B1 (fr) 2008-12-19 2016-07-27 Takeda Pharmaceutical Company Limited Méthode de purification anticorps par chromatographie a mode mixte utilisant une solution de chargement contenant arginine
EP2376523A4 (fr) 2009-01-13 2012-11-28 Ge Healthcare Bio Sciences Ab Précipitation de biomolécules au moyen de polymères chargés négativement
KR101224468B1 (ko) * 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
ES2817802T3 (es) * 2009-08-07 2021-04-08 Emd Millipore Corp Métodos para purificar una proteína objetivo de una o más impurezas en una muestra
EP3736338A1 (fr) * 2009-09-01 2020-11-11 F. Hoffmann-La Roche AG Purification améliorée d'une protéine grâce à une élution modifiée de la protéine a
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
EP2490780A4 (fr) 2009-10-20 2014-04-09 Merck Sharp & Dohme Utilisation de la chromatographie en mode mixte pour la capture et la purification de produits d'anticorps de base
US20130178608A1 (en) * 2009-12-29 2013-07-11 Samir Kulkarni Protein purification by ion exchange
PT2415779E (pt) 2010-08-02 2015-05-13 Ratiopharm Gmbh Processo de produção e purificação de uma sialiltransferase solúvel activa
US20120238730A1 (en) * 2011-03-15 2012-09-20 Abbott Laboratories Integrated approach to the isolation and purification of antibodies
JP6147726B2 (ja) * 2011-03-29 2017-06-14 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ タンパク質精製のためのバッファー系
US8445284B2 (en) 2011-06-17 2013-05-21 Constitution Medical, Inc. Fixative and staining solutions
US9096648B2 (en) 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
EP2578286A1 (fr) * 2011-10-04 2013-04-10 Merck Patent GmbH Procédé et appareil de purification chromatographique
CA2853112C (fr) * 2011-10-25 2018-08-21 Onclave Therapeutics Limited Formulations d'anticorps et procedes correspondants
WO2013075740A1 (fr) 2011-11-23 2013-05-30 Sanofi Procédé de purification d'anticorps

Also Published As

Publication number Publication date
TWI675041B (zh) 2019-10-21
US10793622B2 (en) 2020-10-06
JP2019104735A (ja) 2019-06-27
SG11201508968XA (en) 2015-11-27
EP3301115A1 (fr) 2018-04-04
MX2015015482A (es) 2016-03-21
RU2662668C2 (ru) 2018-07-26
AU2014264697B2 (en) 2019-08-22
BR112015027812A2 (pt) 2017-07-25
MX368177B (es) 2019-09-23
KR20160005047A (ko) 2016-01-13
CY1125281T1 (el) 2023-06-09
KR102272851B1 (ko) 2021-07-02
DK3301115T3 (da) 2022-01-31
CA2911462C (fr) 2021-04-06
JP2016519137A (ja) 2016-06-30
BR112015027812B1 (pt) 2021-03-30
HUE057119T2 (hu) 2022-04-28
EP2994485B1 (fr) 2018-01-10
CA2911462A1 (fr) 2014-11-13
TWI631132B (zh) 2018-08-01
TW201522363A (zh) 2015-06-16
ES2905675T3 (es) 2022-04-11
CN116003579A (zh) 2023-04-25
EP2994485A1 (fr) 2016-03-16
TW201908331A (zh) 2019-03-01
WO2014180852A1 (fr) 2014-11-13
CN105358572A (zh) 2016-02-24
AU2014264697A1 (en) 2015-11-26
HUE038741T2 (hu) 2018-11-28
JP6463734B2 (ja) 2019-02-06
US20160083454A1 (en) 2016-03-24
DK2994485T3 (en) 2018-04-23
RU2015151869A (ru) 2017-06-13
EP3301115B1 (fr) 2021-11-10
IL242408B (en) 2020-04-30
ES2665645T3 (es) 2018-04-26

Similar Documents

Publication Publication Date Title
AP2016009275A0 (fr)
BR112015007533A2 (fr)
BR112014017733A2 (fr)
BR112014018502A2 (fr)
BR112014017739A2 (fr)
BR112014018516A2 (fr)
BR112014018480A2 (fr)
BR112014017855A2 (fr)
BR112014020341A2 (fr)
BR112014017765A2 (fr)
BR112016000440A2 (fr)
BR112016005761A2 (fr)
BR112014019204A2 (fr)
BR112014018468A2 (fr)
BR112014017901A2 (fr)
BR112016000087A2 (fr)
BR112014017722A2 (fr)
BR112014017653A2 (fr)
BR112014017794A2 (fr)
BR112014018483A2 (fr)
BR112015027948A2 (fr)
BR112016000816A2 (fr)
BR112014017601A2 (fr)
BR112014017745A2 (fr)
BR112015015312A2 (fr)